Welcome

Investor Home

Investor Home

Investor Home
Governance
Press Releases
Financials
- - Financials
- - Analyst Coverage
- - SEC Filings
Stock Information
Investor Contact

Investor Contact

Media & Investor Relations:
Troy Wichterman
Chief Financial Officer
(425) 402 - 1400
twichterman@biolifesolutions.com

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
P.O. Box 1342
Brentwood, New York 11717
USA
(877) 830 - 4936
shareholder@broadridge.com

Investor Alerts

Register here to receive email notifications with updates about our press releases, stock price, SEC filings and more.

Investor Home

Investor Presentation

BioLife Solutions Investor Presentation August 2023

Recent Events

BioLife Solutions, Inc. Q2 2023 Earnings Conference Call and Business Update

Tuesday, August 8, 2023

1:30pm - 2:30pm PDT

BioLife Solutions’ Analyst Day Replay

Thursday, March 23, 2023

BioLife Solutions’ Analyst Day PDF Presentation

Thursday, March 23, 2023

Latest News

Get News Alerts by Email

Aug 08, 2023

BioLife Solutions Reports Second Quarter 2023 Financial Results, Updates Full Year 2023 Guidance and Provides Pro Forma First Half 2023 Financial Profile Excluding Freezer Business

Committed to Divesting Stirling Ultracold and Custom Biogenic Systems by End of 2023 Conference call begins at 4:30 p.m. Eastern time today BOTHELL, Wash., Aug. 8, 2023 /PRNewswire/ -- BioLife...

Jul 27, 2023

BioLife Solutions to Provide Second Quarter 2023 Financial Results and Business Update on August 8, 2023

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced...

View All News and Press Releases